SCHEMBL10343

SCHEMBL10343

Cc1[nH]cnc1CN1CCc2[nH]c3ccccc3c2C1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
ADRA2C P18825 1/20 0.63
HTR2A P28223 1/20 0.63
HTR2C P28335 1/20 0.63
ADRA1A P35348 1/20 0.63
HTR2B P41595 1/20 0.63
HTR3A P46098 1/20 0.63
KCNH2 Q12809 1/20 0.63
CASP6 P55212 1/20 0.62
CD44 P16070 2/20 0.44
WDR5 P61964 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL1054 0.92 CYP1A2 (0.55) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Fumaric Acid SCHEMBL1055 0.92 CYP1A2 (0.55) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL7302315 0.83 CYP1A2 (0.56) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL8962749 0.78 CYP1A2 (0.63) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL8962724 0.78 CYP1A2 (0.63) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Maleic Acid SCHEMBL7296071 0.78 CYP1A2 (0.51) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Fumaric Acid SCHEMBL7296076 0.78 CYP1A2 (0.51) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Fumaric Acid SCHEMBL7292841 0.77 CYP1A2 (0.50) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Maleic Acid SCHEMBL7292838 0.77 CYP1A2 (0.50) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Alosetron SCHEMBL631 0.77 KCNH2 (1.00) CYP1A2CYP3A4ADRA2CHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5360800-A Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives GLAXO GROUP LIMITED (GB) 1994-11-01 US disclosed
US-5276050-A Administering for treatment of bulemia or seasonal affective disorder GLAXO GROUP LIMITED (GB) 1994-01-04 US disclosed
US-5225407-A Cognition activators GLAXO GROUP LIMITED (GB) 1993-07-06 US disclosed
EP-0450757-A2 Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood GLAXO GROUP LIMITED (GB) 1991-10-09 EP disclosed